Stockscreener 앱 받기
2.46%
시간 외 거래:
전일 마감가:
$152.54
열려 있는:
$152.03
하루 거래량:
1.08M
Relative Volume:
1.01
시가총액:
$10.45B
수익:
$12.82B
순이익/손실:
$936.34M
주가수익비율:
14.55
EPS:
10.74
순현금흐름:
$1.47B
1주 성능:
+3.70%
1개월 성능:
+48.00%
6개월 성능:
+13.62%
1년 성능:
+6.51%
1일 변동 폭
$151.87
$157.91
1주일 범위
$146.00
$157.91
52주 변동 폭
$101.00
$157.91
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, UHS, ENSG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
156.30 | 10.20B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
529.70 | 117.60B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
239.39 | 20.84B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.46 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
206.10 | 12.77B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
214.17 | 12.36B | 4.11B | 239.98M | 193.10M | 4.12 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Davita Healthcare stock hits 52-week high at 157.25 USD - Investing.com UK
Where Does DaVita Stock Rank Among Competitors? - Trefis
DaVita’s 20-Year Fortune Streak And What It Signals For Investors - Yahoo Finance
DaVita Inc.: Why This Quiet Healthcare Stock Just Got Loud for US Investors - AD HOC NEWS
Does DaVita Stock Lead the Pack? - Trefis
DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies - ACCESS Newswire
Vanguard Group Inc. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference - GuruFocus
DaVita, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
DaVita Stock After Earnings: Hidden Cash Machine or Value Trap? - AD HOC NEWS
Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative - simplywall.st
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
Is It Too Late To Consider DaVita (DVA) After Its Sharp 30 Day Surge - Yahoo Finance
DaVita Inc. (DVA): A Bull Case Theory - MSN
Aberdeen Group plc Decreases Stake in DaVita Inc. $DVA - MarketBeat
Layoff Watch: Can DaVita Inc continue delivering strong returnsJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
Wall Street Zen Upgrades DaVita (NYSE:DVA) to Buy - MarketBeat
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $2.56 Million Stock Holdings in DaVita Inc. $DVA - Defense World
Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments - Yahoo Finance
October 16th Options Now Available For DaVita (DVA) - Nasdaq
DaVita Stock Is Up 35% Since February. Here’s Where Shares Could Go in 2026 - TIKR.com
Skandinaviska Enskilda Banken AB publ Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - AOL.com
Berkshire's New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - GOBankingRates
A | Will DaVita Inc. stock benefit from M&A2025 Market Overview & Weekly High Return Stock Forecasts - mfd.ru
Todd Asset Management LLC Makes New Investment in DaVita Inc. $DVA - MarketBeat
National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney - ACCESS Newswire
DaVita Inc. $DVA Shares Sold by Principal Financial Group Inc. - MarketBeat
Why DaVita (DVA) Is Up 5.8% After Massive Buybacks Amid Softer EarningsAnd What's Next - simplywall.st
Can DaVita Stock Hold Up When Markets Turn? - Trefis
National Donor Day Spotlight: DaVita Patient Care Technician Don - GuruFocus
What are DaVita Inc.’s technical support levelsJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
LSV Asset Management Sells 13,700 Shares of DaVita Inc. $DVA - MarketBeat
Can DaVita Inc. continue delivering strong returnsPortfolio Value Summary & Verified Short-Term Plans - mfd.ru
AlphaQuest LLC Sells 12,031 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Kidney Care Profit Milestone Highlights Emerging Value Based Earnings Mix - Yahoo Finance
The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026 - The Chronicle-Journal
Can DaVita Inc. stock double in next 5 yearsWeekly Investment Recap & Accurate Entry/Exit Alerts - mfd.ru
DaVita Inc (DVA) Stock Price Up 3.19% on Feb 11 - GuruFocus
Gains Report: Will DaVita Inc benefit from seasonalityJuly 2025 PostEarnings & Long-Term Capital Growth Strategies - baoquankhu1.vn
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call - Yahoo Finance
DaVita Inc. (DVA) Investor Outlook: Analyzing the Healthcare Leader with a 7.73% Upside Potential - DirectorsTalk Interviews
2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid - The Motley Fool
DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com
DaVita (DVA) Surges as Top Healthcare Gainer in S&P 500 - GuruFocus
DaVita (DVA) Is Up 28.8% After Strong 2026 Guidance And Heavy BuybacksWhat's Changed - simplywall.st
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
자본화:
|
볼륨(24시간):